Lung, Mediastinal and Pleural Neoplasm - Non-Small Cell Lung Cancer
NCT00499330
Clinical Trial Information
Trial Number: NCT00499330 (ClinicalTrials.gov)
Disease Type:
- Lung, Mediastinal and Pleural Neoplasm - Non-Small Cell Lung Cancer
Trial Title:
A Phase III Randomized Trial of Lobectomy Versus Sublobar Resection for Small (≤ 2 cm) Peripheral Non-Small Cell Lung Cancer
Study ID:
CALGB-140503
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00499330-D1 | There is one data submission for PMID 36780674. This dataset, NCT0049930-D1, contains data presented in the baseline characteristics table, primary analysis, the first three objectives of the secondary analysis, the per-protocol analysis, and an additional site analysis. |
NCT02785952
Clinical Trial Information
Trial Number: NCT02785952 (ClinicalTrials.gov)
Disease Type:
- Lung, Mediastinal and Pleural Neoplasm - Non-Small Cell Lung Cancer
Trial Title:
A Phase III Randomized Study of Nivolumab plus Ipilimumab versus Nivolumab for Previously Treated Patients with Stage IV Squamous Cell Lung Cancer and No Matching Biomarker (Lung-MAP Sub-Study)
Study ID:
S1400I
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT02785952-D3 | There are three datasets for PMID 34264316 containing the results reported in JAMA Oncology (Gettinger et al., JAMA Oncology, 2021). This dataset, NCT02785952-D3, contains biomarker data (one row per patient per gene alteration). |
| NCT02785952-D2 | There are three datasets for PMID 34264316 containing the results reported in JAMA Oncology (Gettinger et al., JAMA Oncology, 2021). This toxicity dataset, NCT02785952-D2, contains event-level data (one row per patient per adverse event experienced on trial). |
| NCT02785952-D1 | There are three datasets for PMID 34264316 containing the results reported in JAMA Oncology (Gettinger et al., JAMA Oncology, 2021). This clinical dataset, NCT02785952-D1, contains patient-level data (one row per patient), including baseline, demographic, and treatment information. It also contains assessment data. |
NCT01107626
Clinical Trial Information
Trial Number: NCT01107626 (ClinicalTrials.gov)
Disease Type:
- Lung, Mediastinal and Pleural Neoplasm - Non-Small Cell Lung Cancer
Trial Title:
Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Pemetrexed, or a Combination of Bevacizumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced Non-Squamous NSCLC
Study ID:
E5508
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT01107626-D2 | There are two different submissions for PMID 31361535 from trial E5508. This dataset, NCT01107626-D2, contains toxicity data. Dataset NCT01107626-D1 contains baseline, treatment, and efficacy data. |
| NCT01107626-D1 | There are two different submissions for PMID 31361535 from trial E5508. This dataset, NCT01107626-D1, contains baseline, treatment, and efficacy data. Dataset NCT01107626-D2 contains toxicity data. |
NCT02349412
Clinical Trial Information
Trial Number: NCT02349412 (ClinicalTrials.gov)
Disease Type:
- Gastrointestinal Neoplasm - Gastroesophageal Cancer
- Gastrointestinal Neoplasm - Liver and Hepatobiliary Cancer
- Gastrointestinal Neoplasm - Pancreatic Cancer (excluding Islets)
- Lung, Mediastinal and Pleural Neoplasm - Mesothelioma
- Lung, Mediastinal and Pleural Neoplasm - Non-Small Cell Lung Cancer
- Lung, Mediastinal and Pleural Neoplasm - Small Cell Lung Cancer
Trial Title:
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers
Study ID:
A221303
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT02349412-D9 | Dataset NCT02349412-D9-Dataset.csv (nctn_supp_table3) is one of 9 datasets associated with PubMed ID 32031887. This dataset contains information that will allow you to reproduce Supplementary Table 3 from the manuscript. |
| NCT02349412-D8 | Dataset NCT02349412-D8-Dataset.csv (nctn_supp_table2) is one of 9 datasets associated with PubMed ID 32031887. This dataset contains information that will allow you to reproduce Supplementary Table 2 from the manuscript. |
| NCT02349412-D7 | Dataset NCT02349412-D7-Dataset.csv (nctn_supp_table1) is one of 9 datasets associated with PubMed ID 32031887. This dataset contains information that will allow you to reproduce Supplementary Table 1 from the manuscript. |
| NCT02349412-D6 | Dataset NCT02349412-D6-Dataset.csv (nctn_fig2) is one of 9 datasets associated with PubMed ID 32031887. This dataset contains information that will allow you to reproduce Figure 2 from the manuscript. |
| NCT02349412-D5 | Dataset NCT02349412-D5-Dataset.csv (nctn_table4) is one of 9 datasets associated with PubMed ID 32031887. This dataset contains information that will allow you to reproduce Table 4 from the manuscript. |
| NCT02349412-D4 | Dataset NCT02349412-D4-Dataset.csv (nctn_table3) is one of 9 datasets associated with PubMed ID 32031887. This dataset contains information that will allow you to reproduce Table 3 from the manuscript. |
| NCT02349412-D3 | Dataset NCT02349412-D3-Dataset.csv (nctn_table2) is one of 9 datasets associated with PubMed ID 32031887. This dataset contains information that will allow you to reproduce Table 2 from the manuscript. |
| NCT02349412-D2 | Dataset NCT02349412-D2-Dataset.csv (nctn_table1) is one of 9 datasets associated with PubMed ID 32031887. This dataset contains information that will allow you to reproduce Table 1 (Baseline characteristics) from the manuscript. |
| NCT02349412-D1 | Dataset NCT02349412-D1-Dataset.csv (nctn_consort) is one of 9 datasets associated with PubMed ID 32031887. This dataset contains information that will allow you to reproduce the consort diagram. |
NCT01642251
Clinical Trial Information
Trial Number: NCT01642251 (ClinicalTrials.gov)
Disease Type:
- Lung, Mediastinal and Pleural Neoplasm - Non-Small Cell Lung Cancer
- Lung, Mediastinal and Pleural Neoplasm - Small Cell Lung Cancer
Trial Title:
Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer
Study ID:
E2511
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT01642251-D2 | There are two different submissions (each with one dataset) for PMID 30523756 from ECOG-ACRIN trial E2511. This dataset, NCT01642251-D2 contains toxicity data. Dataset NCT01642251-D1 contains baseline, treatment, and efficacy data. |
| NCT01642251-D1 | There are two different submissions (each with one dataset) for PMID 30523756 from ECOG-ACRIN trial E2511. This dataset, NCT01642251-D1, contains baseline, treatment, and efficacy data. Dataset NCT01642251-D2 contains toxicity data. |
NCT00946712
Clinical Trial Information
Trial Number: NCT00946712 (ClinicalTrials.gov)
Disease Type:
- Lung, Mediastinal and Pleural Neoplasm - Non-Small Cell Lung Cancer
Trial Title:
A Randomized, Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab With or Without Concurrent Cetuximab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
Study ID:
S0819
Images are available?:
Yes
Imaging data can be requested via the NCTN/NCORP Data Archive. To view imaging data details before requesting data here, visit:
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00946712-D3 | There are three data submissions associated with PMID 29169877: NCT00946712-D1, -D2, and -D3. This dataset, NCT00946712-D3, will allow users to reproduce the results reported in the Lancet Oncology (Herbst et al., Lancet Oncology, 2018). This dataset contains reasons for off treatment due to toxicity. |
| NCT00946712-D2 | There are three data submissions associated with PMID 29169877: NCT00946712-D1, -D2, and -D3. This toxicity dataset, NCT00946712-D2, will allow users to reproduce the results reported in the Lancet Oncology (Herbst et al., Lancet Oncology, 2018). This dataset contains event-level information (one row per patient per adverse event experienced on trial). |
| NCT00946712-D1 | There are three data submissions associated with PMID 29169877: NCT00946712-D1 , -D2, and -D3. This clinical dataset, NCT00946712-D1, will allow users to reproduce the results reported in the Lancet Oncology (Herbst et al., Lancet Oncology, 2018). This dataset contains patient-level data (one row per patient), including eligibility, evaluability, treatment, demographic, and baseline information. It also contains assessment data. |
NCT00324805
Clinical Trial Information
Trial Number: NCT00324805 (ClinicalTrials.gov)
Disease Type:
- Lung, Mediastinal and Pleural Neoplasm - Non-Small Cell Lung Cancer
Trial Title:
A Phase III Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab for Patients With Completely Resected Stage IB (≥ 4 cm) - IIIA Non-small Cell Lung Cancer (NSCLC)
Study ID:
E1505
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00324805-D4 | There are four different submissions (each with one dataset) for PMID 29129443 (trial NCT00324805). This dataset, NCT00324805-D4, can be used to derive the number of patients with worst degree 1/2 toxicities (bottom row of Table 2); and the worst degree grade 3-5 events in Table 3 and Supplement. Dataset NCT00324805-D1 contains baseline, treatment, and efficacy data. Dataset NCT00324805-D2 contains toxicity data for duplicating the results in Table 2 of the manuscript. Dataset NCT00324805-D3 contains toxicity data for duplicating the results in Table 3 of the manuscript. |
| NCT00324805-D3 | There are four different submissions (each with one dataset) for PMID 29129443 (trial NCT00324805). This dataset, NCT00324805-D3, contains toxicity data for duplicating the results in Table 3 of the manuscript. Dataset NCT00324805-D1 contains baseline, treatment, and efficacy data. Dataset NCT00324805-D2 contains toxicity data for duplicating the results in Table 2 of the manuscript. Dataset NCT00324805-D4 can be used to derive the number of patients with worst degree 1/2 toxicities (bottom row of Table 2); and the worst degree grade 3-5 events in Table 3 and Supplement. |
| NCT00324805-D2 | There are four different submissions (each with one dataset) for PMID 29129443 (trial NCT00324805). This dataset, NCT00324805-D2, contains toxicity data for duplicating the results in Table 2 of the manuscript. Dataset NCT00324805-D1 contains baseline, treatment, and efficacy data. Dataset NCT00324805-D3 contains toxicity data for duplicating the results in Table 3 of the manuscript. Dataset NCT00324805-D4 can be used to derive the number of patients with worst degree 1/2 toxicities (bottom row of Table 2); and the worst degree grade 3-5 events in Table 3 and Supplement. |
| NCT00324805-D1 | There are four different submissions (each with one dataset) for PMID 29129443 (trial NCT00324805). This dataset, NCT00324805-D1, contains baseline, treatment, and efficacy data. Dataset NCT00324805-D2 contains toxicity data for duplicating the results in Table 2 of the manuscript. Dataset NCT00324805-D3 contains toxicity data for duplicating the results in Table 3 of the manuscript. Dataset NCT00324805-D4 can be used to derive the number of patients with worst degree 1/2 toxicities (bottom row of Table 2); and the worst degree grade 3-5 events in Table 3 and Supplement. |
NCT00693992
Clinical Trial Information
Trial Number: NCT00693992 (ClinicalTrials.gov)
Disease Type:
- Lung, Mediastinal and Pleural Neoplasm - Non-Small Cell Lung Cancer
Trial Title:
Randomized, Phase III, Double-Blind Placebo-Controlled Trial of Sunitinib (NSC #736511) as Maintenance Therapy in Non-progressing Patients Following an Initial Four Cycles of Platinum-Based Combination Chemotherapy in Advanced, Stage IIIB / IV Non-small Cell Lung Cancer
Study ID:
CALGB-30607
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00693992-D3 | Dataset NCT00693992-D3-Dataset.csv (qol) is one of 3 datasets associated with PubMed ID 28161554. This dataset contains information that will allow you to reproduce the quality of life (qol) analysis. Due to data cleaning efforts, values may contain slight discrepancies from that reported in Table 1 of the Supplemental Materials. |
| NCT00693992-D2 | Dataset NCT00693992-D2-Dataset.csv (toxicity) is one of 3 datasets associated with PubMed ID 28161554. This dataset contains information that will allow you to reproduce the toxicity analysis. |
| NCT00693992-D1 | Dataset NCT00693992-D1-Dataset.csv (clinical) is one of 3 datasets associated with PubMed ID 28161554. This dataset contains information that will allow you to reproduce the baseline characteristics table and primary analysis. |
NCT01041781
Clinical Trial Information
Trial Number: NCT01041781 (ClinicalTrials.gov)
Disease Type:
- Lung, Mediastinal and Pleural Neoplasm - Non-Small Cell Lung Cancer
Trial Title:
A Randomized Phase III Double Blind Trial Evaluating Selective COX-2 Inhibition in COX-2 Expressing Advanced Non-Small Cell Lung Cancer
Study ID:
CALGB-30801
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT01041781-D2 | Dataset NCT01041781-D2-Dataset.csv (c30801_ae) is one of 2 datasets associated with PubMed ID 28489511. This dataset contains information that will allow you to reproduce the adverse events analysis. Due to further data cleaning subsequent to the JCO publication, there are slight discrepancies in the numbers of patients reporting various grade 3 adverse events from those reported in Table A3 in the publication. |
| NCT01041781-D1 | Dataset NCT01041781-D1-Dataset.csv (c30801) is one of 2 datasets associated with PubMed ID 28489511. This dataset contains information that will allow you to reproduce the baseline characteristics table and primary analysis. In Table A5, there is a typo in the median number of OS months for Celecoxib patients with COX-2 >= 2. The correct numbers should be 15.73 (11.50-18.96) and they are the same as those present on this shared dataset. |
NCT00533949
Clinical Trial Information
Trial Number: NCT00533949 (ClinicalTrials.gov)
Disease Type:
- Lung, Mediastinal and Pleural Neoplasm - Non-Small Cell Lung Cancer
Trial Title:
A Randomized Phase III Comparison of Standard-Dose (60 Gy) Versus High-Dose (74 Gy) Conformal Radiotherapy With Concurrent and Consolidation Carboplatin/Paclitaxel +/- Cetuximab (IND #103444) in Patients With Stage IIIA/IIIB Non-Small Cell Lung Cancer
Study ID:
RTOG-0617
Images are available?:
Yes
Imaging data can be requested via the NCTN/NCORP Data Archive. To view imaging data details before requesting data here, visit:
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00533949-D3 | This dataset will allow users to reproduce adverse event tables in trial NCT00533949. |
| NCT00533949-D2 | This dataset will allow users to reproduce the adverse event tables in trial NCT00533949. |
| NCT00533949-D1 | This dataset will allow users to reproduce the treatment comparison between arms in trial NCT00533949. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®